This article has two aims: the first is to propose a definition for social collaborative companies that encompasses their main characteristics, and once which we refer settled, second aim quality model companies. These are of particular type based on business with focus as part mission. They employ democratic style governance, whether or not they cooperatives, operate through platform in enviro...

Reported cases of cyclical Cushing's syndrome are rare. Of 14 successive patients with Cushing's syndrome nine collected sequential urine samples for the estimation of cortisol:creatinine ratio. Five had cyclical Cushing's syndrome while two had considerable variation in urinary cortisol excretion without a cyclical pattern being established. Two of the five patients with a cyclical syndrome ha...

Over the last two decades, emerging Chinese Party-state has used commercial ties with North American and European providers of surveillance technologies to grow national prowess public security, fostering a transnational state-corporate symbiosis. The exports from Global China started in late 1970s, now technology companies are competing replacing those suppliers globalized neoliberal market. T...

Cyclical mastalgia is a common complaint, with a potentially important relationship to breast cancer risk. In the last decade, case-control studies have reported that cyclical mastalgia could be considered as an independent risk factor for breast cancer. The subjectivity of a retrospectively collected symptom questioned the validity of this finding. We have examined the association between cycl...

This study aims to analyze the effect of good corporate governance and environmental performance on company's financial performance. The population this are non-cyclical consumer sector companies listed Indonesia Stock Exchange (IDX) in 2019 2021. Based criteria determined using purposive sampling technique, a research sample 81 was generated for three years. method used is multiple regression ...

opening the market early for consumers and for funding the expensive lawsuit. Yet Cobalt, which had agreed to delay consumer access to the generic brand by abandoning its effort to knock out what proved to be a patent that never should have been issued in the first place, was able to “double-dip.” Cobalt was able to keep the money it was paid by the brand-name drug company to abandon the patent...